|
|
Subscribe
to our newsletter:
| |
|
|
|
|
Search results for: ether
11 - 15 of 287 <<previous | next>>
Drugs results:
|
Tramadol, also called Ultram, is an analgesic used to relieve pain, including use after surgery. The effects of Tramadol are similar to those of narcotic analgesics, and though it is not considered narcotic, it may become habit forming.
Be sure to tel more...
|
|
Ultram, also called Tramadol, is an analgesic used to relieve pain, including use after surgery. The effects of Ultram are similar to those of narcotic analgesics, and though it is not considered narcotic, it may become habit forming.
Be sure to tell more...
|
|
Sometimes known as Orlistat, Xenical is a lipase inhibitor that is used as an aid to help you lose weight, by preventing the digestion of some of the fat you eat. Fats that are not digested cannot be absorbed and therefore do not cont more...
|
|
Ambien or Zolpidem belongs to the group of medicines called Central Nervous System (CNS) depressants, and is used to treat insomnia.
Be sure to tell your doctor of any allergies you have whether it is to medication or food, preservatives, or dyes. Tel more...
|
|
Carisoprodol, one of a group of Skeletal Muscle Relaxants, are used to relax certain muscles in your body and relieve the stiffness, pain, and discomfort caused by strains, sprains, or other injury to your muscles. Skeletal Muscle Relaxants act in the cen more...
|
Diseases results:Pain relief
Obesity
Sleep disorder
Muscle pain
Epilepsy
Periodontal disease
Menopause
Hiv
PeritonitisArticles results:
| Biotechs Expand Into Small Molecules For Drug Discovery |
Biotech companies traditionally focus on large proteins in their quest to find new drugs. But faced with the complex nature of disease, these companies are increasingly turning to small molecules as well. This new push into small-molecule drug design, which researchers hope will deliver better and more effective disease treatments, is explored in a report scheduled for the Oct. 30 issue of Chemical & Engineering News, the ACS's weekly newsmagazine.Associate Editor Lisa M.
|
| Mount Sinai Receives Grant From US Attorney General Office |
The Office of the US Attorney General announced today The Mount Sinai Medical Center will be one of five recipients of a prescription drug education grant for health care professionals. The $400,000 grant is funded by the Attorney General Consumer and Prescriber Education Grant Program and will be used to educate physicians and medical students about pharmaceutical company marketing practices and promote evidence-based prescribing practices.
|
| Containment Technologies Group, Inc. Introduces New Aseptic Hospital Isolator Technology |
Containment Technologies Group, Inc. announces a new advanced aseptic compounding isolator for pharmacy-compounded sterile preparations. The Mobile Isolation Chamber-Environmental Decontamination Unit (MIC-EDU) utilizes Vaprox(R) Hydrogen Peroxide Sterilant to treat the exterior of components before they are placed in hospital ISO Class 5 environments for compounding.
|
| Biotech Industry Welcomes WHO Initiative On Naming Of Biologicals Including Biosimilar Medicines |
On Monday 13 November, the Biotech industry will call on the WHO to address the naming (1) of biologicals including biosimilar medicines in the interests of patients and public health at the upcoming meeting for stakeholders organised by the WHO in Geneva (November 13, 2006).EuropaBio welcomes this opportunity by the WHO and the international community to discuss and debate the issues related to the naming of biologicals and biosimilar medicines.
|
11 - 15 of 287 <<previous | next>>
|
|
|
